similar to other tools. the author says "RustViz is a bit more of a purely educational tool, as code has to be annotated manually, while Boris aims to be more of a development assistance"

it would be really great to have a lemmy client (or feature of existing client) that allows for batch downloading of a user specified list of communities.
this would allow a user to download all the content for the day or week on wifi internet and then depart from the source of internet but slowly & carefully read a selection of material(text posts, comment discussion, and even images like memes).
one benefit is that it would be extra impossible to see what users are loading/viewing because they already loaded everything and are disconnected from the internet entirely. performance is also good because there is no network latency that would be experienced, each time, when accessing the servers.

The FCC said in a release that current funding is projected to run out in April and households will receive benefits through the end of the month. The program needs a $6 billion infusion to extend the program through 2024, according to the White House.

A bipartisan group of six lawmakers — including Democrat Sen. Peter Welch from Vermont and Republican Sen. JD Vance from Ohio — called for additional funding through the Affordable Connectivity Program Extension Act, according to a news release.

Through its savvy but legal exploitation of the U.S. patent system, Humira’s manufacturer, AbbVie, blocked competitors from entering the market. For the next six years, the drug’s price kept rising. Today, Humira is the most lucrative franchise in pharmaceutical history. AbbVie orchestrated the delay by building a formidable wall of intellectual property protection and suing would-be competitors before settling with them to delay their product launches until this year. Over the past 20 years, AbbVie and its former parent company increased Humira’s price about 30 times, most recently by 8 percent this month. Since the end of 2016, the drug’s list price has gone up 60 percent to over $80,000 a year, according to SSR Health, a research firm. AbbVie did not invent these patent-prolonging strategies; companies like Bristol Myers Squibb and AstraZeneca have deployed similar tactics to maximize profits on drugs for the treatment of cancer, anxiety and heartburn. But AbbVie’s success with Humira stands out even in an industry adept at manipulating the U.S. intellectual-property regime.

“Humira is the poster child for many of the biggest concerns with the pharmaceutical industry,” said Rachel Sachs, a drug pricing expert at Washington University in St. Louis. “AbbVie and Humira showed other companies what it was possible to do.”

Lawyers for the unnamed girl said her parents took her to Frimley Park Hospital in Surrey, southeast England, with a high fever, drowsiness, and vomiting, Metro reported. These symptoms are "red flags for meningitis and sepsis," according to the BBC News, but doctors sent her home with paracetamol, or acetaminophen.

Her parents returned to the hospital when her condition worsened, and doctors diagnosed her with meningococcal sepsis. She later experienced multi-organ failure.

The severity of her sepsis later led to her needing the quadruple-limb amputations, Elizabeth-Anne Gumbel KC, who is representing the family, said, the BBC reported. The girl had above-knee amputations of both legs, and above-elbow amputations of her arms.

Her family argued that if doctors had immediately treated her with antibiotics, she would not have been so ill and might have kept her limbs.

florida eviction

Relatelist.com is the special search engine for Business intelligence.

We research published in Internet documents on almost all web-sites.

Actually we know more than 45 million people from about 6 million companies.

With Relatelist.com you may see another side of corporate world. Use it to discover the real relationship between big and small companies, goverments, media and military agencies, intelligence service, banks, international organisations etc.